CACNA1A

Clinical trials for CACNA1A explained in plain language.

Never miss a new study

Get alerted when new CACNA1A trials appear

Sign up with your email to follow new studies for CACNA1A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a simple amino acid ease rare brain disorders?

Disease control Not yet recruiting

This study tests an experimental drug, N-acetyl-L-leucine, for people with rare genetic conditions caused by changes in the CACNA1A gene. These conditions can cause problems with movement, balance, and severe migraines. The study will include 60 people aged 4 and older, and will …

Matched conditions: CACNA1A

Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control

Last updated May 17, 2026 09:18 UTC

CACNA1A

Get alerted when new CACNA1A trials appear

Could a simple amino acid ease rare brain disorders?